Two Top Stories of Wall Street: ArcelorMittal (NYSE:MT), Jaguar Animal Health, Inc. (NASDAQ:JAGX)

ArcelorMittal (NYSE:MT)

The shares of ArcelorMittal (NYSE:MT) started off the last trading session with the price of $32.58 while closing the day with the price of $31.46. The shares of ArcelorMittal (NYSE:MT) Fell -6.01% with the Loss of -1.12 points.

The shares of ArcelorMittal (NYSE:MT) traded with the day volume of 3.86 Million shares whereas its average trading volume is 3.47 Million.

While analyzing the past performance of the stock we can see that the shares of ArcelorMittal (NYSE:MT) Loss -3.2% in the last week while Falling -9.26% in the last month. Past quarter performance shows the red light with -1.35%. The semi-annual and annual performance shows 17.17% and 19.03% respectively.

Some critical values of the shares of ArcelorMittal (NYSE:MT) to be discussed here are: the beta which shows the value at 2.86 while Average True Range of ArcelorMittal (NYSE:MT) demonstrate the value at 0.97. The weekly and monthly volatility of the shares of ArcelorMittal (NYSE:MT) are indicated at 2.77% and 2.26%. Also to discuss here is the Relative Strength Index or RSI which is depicted at 38.6.

While studying the financial position of the shares of ArcelorMittal (NYSE:MT), we can see that the Market capitalization of the company is at 32.29 Billion. The shares outstanding for the company is 1.03 Billion and the shares float stands at 639.96 Million. The income of the company stand at 4.57 Billion while the sales stand at 68.68 Billion.

Here are some critical ratios for a financial perspective: Earnings Per Share or EPS of the company stand at 4.46, Price to Earnings or P/E is at 7.05, Price to Sales P/S show the value of 0.47, the Return on Asset ROA stood at 0.055 and the Return on Equity ROE depicted at 0.13 while Return on Investment ROI is at 0.097.


Jaguar Animal Health, Inc. (NASDAQ:JAGX)

Jaguar Animal Health, Inc. (NASDAQ:JAGX) started its previous trading session at $0.2 and closed at $0.2 showing a Fell of -1.7 Percent.

The Company traded with an average Volume of 10.87 Million whereas, its Day Volume stood at 3.85 Million.

Looking at the performance of the stock, Jaguar Animal Health, Inc. (NASDAQ:JAGX) Loss -9.71% in the last week in its shares price and 39.18% in the last month. Quarterly performance shows a green of 62.07 Percent while Semi-Annual and Annual performances shows a -49.97 and -78.93 percent respectively.

Beta for Jaguar Animal Health, Inc. (NASDAQ:JAGX) stands at 0 while the ATR (average true range) is at 0.03. The Stock’s Weekly and Monthly Volatility is 11.97% and 22.67% respectively showing a RSI value of 52.15.

While studying the financial position of the shares of Jaguar Animal Health, Inc. (NASDAQ:JAGX), we can see that the Market capitalization of the company is at 20.35 Million. The shares outstanding for the company is 103.76 Million and the shares float stands at 58.58 Million.

The Company generated an income of -5400000 and the sales of 2.8 Million in the Trailing Twelve Months period.

While analyzing the stock from technical aspects, Diluted Earnings per share stands at $-0.67 a share. P/E (price to earnings) and P/S (price to sales) values are 0 and 7.27 respectively.

The Return on Assets stands at -0.302, ROE shows a value of -1.287 and ROI for Jaguar Animal Health, Inc. (NASDAQ:JAGX) is -9.781 as of Trailing Twelve Months period.

The following two tabs change content below.

Eldred Matthew

Eldred Matthew covers Healthcare Sector Company recent Press Releases news updates. He has three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

View all contributions by

Eldred Matthew covers Healthcare Sector Company recent Press Releases news updates. He has three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

Leave a Comment